OREXIGEN THERAPEUTICS INC (OTCMKTS:OREXQ) had an increase of its shares shorted by 13.97%. FINRA published shares shorted of OREXQ’s total 211,300 shares. The up change of 13.97% from 185,400 shares was reported. Previous OREXQ’s position will need 2 days to recover. It has 144,800 average volume.

OREXQ reached $0.007 during the last trading session after $0.0015 change.Orexigen Therapeutics, Inc. has volume of 30,627 shares. Since April 8, 2018 OREXQ has 0.00% and is . The stock underperformed the S&P500 by 4.37%.

Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical products primarily in the United States, Europe, and South Korea.The company has $132,209 market cap. It offers Contrave for the treatment of obesity.Last it reported negative earnings. The firm also offers Contrave under the Mysimba brand name.

Another two news for Orexigen Therapeutics, Inc. (OTCMKTS:OREXQ) were briefly announced by: Investorplace.com on February 11, 2019 with title “Don’t Get Trapped by All the Hype Surrounding Cronos Stock – Investorplace.com”. The other Gurufocus.com‘s article was titled “Seth Klarman Dives Into Orexigen in Wake of Sale – GuruFocus.com” and announced on April 27, 2018.